Researchers are working to harmonize the multiple diagnostic tests used to predict which non-small cell lung cancer patients are likely to do well on a relatively new class of immunotherapy drugs.
Low premiums are an advantage of high-deductible health insurance plans. But cancer and its treatments can leave patients facing a growing pile of bills before and after they meet their deductible.
Jessica Winter discusses how her research changed after a breast cancer diagnosis and offers advice for patients with cancer.
Receive monthly updates, including information about web exclusives, events, resources, articles and highlights from new issues—direct to your email inbox. Be among the first to hear the latest news from Cancer Today! Click here to sign up!